The US FDA just gave a widely used diabetes medicine a bigger job. lower the risk of heart attacks and strokes in adults with type 2 diabetes at high risk, an expansion that matters for Filipino patients who can already get the drug locally.
What the approval changes
The US FDA approved Mounjaro to reduce the risk of major adverse cardiovascular events, defined as cardiovascular death, non-fatal heart attack, or non-fatal stroke, in adults with type 2 diabetes who are at high risk. It is a dual GIP and GLP-1 hormone receptor agonist from Eli Lilly. Mounjaro was already approved to improve blood sugar in adults and children 10 and older with type 2 diabetes.
In the United States, the most prescribed branded diabetes medicine for adults, and Lilly says the new indication builds on its track record in both blood sugar control and weight.
Why the heart data matters
The approval rests on the SURPASS-CVOT trial, the first cardiovascular outcomes study to compare two incretin medicines head to head rather than against a placebo. It enrolled more than 13,000 participants across 30 countries over more than four and a half years. In the trial, Mounjaro showed an 8 percent lower rate of cardiovascular death, heart attack, or stroke compared with Trulicity (dulaglutide), a GLP-1 medicine with established heart benefit.
| Indicator | Detail |
|---|---|
| Drug | Mounjaro (tirzepatide), dual GIP and GLP-1 receptor agonist |
| New FDA use | Lower risk of heart attack, stroke, or cardiovascular death in high-risk type 2 diabetes adults |
| Trial | SURPASS-CVOT, 13,000+ participants in 30 countries |
| Result | 8% lower cardiovascular event rate vs Trulicity |
| PH availability | Marketed locally and exclusively by Zuellig Pharma |
What it means in the Philippines
Mounjaro is not new to the Philippine market. marketed locally and exclusively by Zuellig Pharma, and it has been available in Philippine drugstores since late 2025. Because it is prescription-only, patients need a doctor’s clearance before using it.
The same regulators and medical societies have also been warning against illegally compounded tirzepatide sold online, which carries unknown health risks. Stick to registered products from authorized pharmacies.
Takeaway for Filipino patients
For adults with type 2 diabetes, the news is another option for protecting the heart while managing blood sugar. If you want to understand how these newer medicines fit alongside older ones, read our explainer on GLP-1 and peptide drugs, and check out our guide to managing diabetes. As always, talk to your doctor before starting, stopping, or changing any treatment.
This article is for informational purposes only and is not medical advice. Consult a qualified healthcare professional before starting, stopping, or changing any treatment.
